AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform.
AUM LifeTech has raised $400K in total funding. The most recent round was Grant. The last funding was announced in August 2022.
AUM LifeTech's investors include National Cancer Institute.
AUM LifeTech is headquartered in Philadelphia, United States.
AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform.
AUM LifeTech is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AUM LifeTech — Funding & Investors." VCBacked, August 17, 2022, https://www.vcbacked.co/company/aum-lifetech. Accessed November 13, 2026.
VCBacked. (2022). AUM LifeTech — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/aum-lifetech
{{cite web |title=AUM LifeTech — Funding & Investors |url=https://www.vcbacked.co/company/aum-lifetech |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at AUM LifeTech? Request a listing update